-
Something wrong with this record ?
Interaction of poly-l-lysine coating and heparan sulfate proteoglycan on magnetic nanoparticle uptake by tumor cells
WX. Siow, YT. Chang, M. Babič, YC. Lu, D. Horák, YH. Ma,
Language English Country New Zealand
Document type Journal Article
NLK
Directory of Open Access Journals
from 2006
Free Medical Journals
from 2006
PubMed Central
from 2006
Europe PubMed Central
from 2006
ProQuest Central
from 2012-01-01
Open Access Digital Library
from 2006-01-01
Open Access Digital Library
from 2009-01-01
Taylor & Francis Open Access
from 2006-09-01
Medline Complete (EBSCOhost)
from 2012-01-01
Health & Medicine (ProQuest)
from 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2006
PubMed
29599614
DOI
10.2147/ijn.s156029
Knihovny.cz E-resources
- MeSH
- Cell Membrane metabolism MeSH
- Dextrans chemistry metabolism MeSH
- Human Umbilical Vein Endothelial Cells MeSH
- Glioma drug therapy pathology MeSH
- HeLa Cells MeSH
- Heparan Sulfate Proteoglycans chemistry metabolism MeSH
- Humans MeSH
- Magnetite Nanoparticles administration & dosage chemistry MeSH
- Magnetic Fields MeSH
- Cell Line, Tumor MeSH
- Polylysine chemistry metabolism pharmacokinetics MeSH
- Polysaccharide-Lyases metabolism MeSH
- Microscopy, Electron, Transmission MeSH
- Iron metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Background: Poly-l-lysine (PLL) enhances nanoparticle (NP) uptake, but the molecular mechanism remains unresolved. We asked whether PLL may interact with negatively charged glycoconjugates on the cell surface and facilitate uptake of magnetic NPs (MNPs) by tumor cells. Methods: PLL-coated MNPs (PLL-MNPs) with positive and negative ζ-potential were prepared and characterized. Confocal and transmission electron microscopy was used to analyze cellular internalization of MNPs. A colorimetric iron assay was used to quantitate cell-associated MNPs (MNPcell). Results: Coadministration of PLL and dextran-coated MNPs in culture enhanced cellular internalization of MNPs, with increased vesicle size and numbers/cell. MNPcell was increased by eight- to 12-fold in response to PLL in a concentration-dependent manner in human glioma and HeLa cells. However, the application of a magnetic field attenuated PLL-induced increase in MNPcell. PLL-coating increased MNPcell regardless of ζ-potential of PLL-MNPs, whereas magnetic force did not enhance MNPcell. In contrast, epigallocatechin gallate and magnetic force synergistically enhanced PLL-MNP uptake. In addition, heparin, but not sialic acid, greatly reduced the enhancement effects of PLL; however, removal of heparan sulfate from heparan sulfate proteoglycans of the cell surface by heparinase III significantly reduced MNPcell. Conclusion: Our results suggest that PLL-heparan sulfate proteoglycan interaction may be the first step mediating PLL-MNP internalization by tumor cells. Given these results, PLL may facilitate NP interaction with tumor cells via a molecular mechanism shared by infection machinery of certain viruses.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18024281
- 003
- CZ-PrNML
- 005
- 20180712115642.0
- 007
- ta
- 008
- 180709s2018 nz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2147/IJN.S156029 $2 doi
- 035 __
- $a (PubMed)29599614
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a nz
- 100 1_
- $a Siow, Wei Xiong $u Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Guishan, Taoyuan, Taiwan, Republic of China. Department of Physiology and Pharmacology and Healthy Aging Research Center, College of Medicine, Chang Gung University, Guishan, Taoyuan, Taiwan, Republic of China.
- 245 10
- $a Interaction of poly-l-lysine coating and heparan sulfate proteoglycan on magnetic nanoparticle uptake by tumor cells / $c WX. Siow, YT. Chang, M. Babič, YC. Lu, D. Horák, YH. Ma,
- 520 9_
- $a Background: Poly-l-lysine (PLL) enhances nanoparticle (NP) uptake, but the molecular mechanism remains unresolved. We asked whether PLL may interact with negatively charged glycoconjugates on the cell surface and facilitate uptake of magnetic NPs (MNPs) by tumor cells. Methods: PLL-coated MNPs (PLL-MNPs) with positive and negative ζ-potential were prepared and characterized. Confocal and transmission electron microscopy was used to analyze cellular internalization of MNPs. A colorimetric iron assay was used to quantitate cell-associated MNPs (MNPcell). Results: Coadministration of PLL and dextran-coated MNPs in culture enhanced cellular internalization of MNPs, with increased vesicle size and numbers/cell. MNPcell was increased by eight- to 12-fold in response to PLL in a concentration-dependent manner in human glioma and HeLa cells. However, the application of a magnetic field attenuated PLL-induced increase in MNPcell. PLL-coating increased MNPcell regardless of ζ-potential of PLL-MNPs, whereas magnetic force did not enhance MNPcell. In contrast, epigallocatechin gallate and magnetic force synergistically enhanced PLL-MNP uptake. In addition, heparin, but not sialic acid, greatly reduced the enhancement effects of PLL; however, removal of heparan sulfate from heparan sulfate proteoglycans of the cell surface by heparinase III significantly reduced MNPcell. Conclusion: Our results suggest that PLL-heparan sulfate proteoglycan interaction may be the first step mediating PLL-MNP internalization by tumor cells. Given these results, PLL may facilitate NP interaction with tumor cells via a molecular mechanism shared by infection machinery of certain viruses.
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a buněčná membrána $x metabolismus $7 D002462
- 650 _2
- $a dextrany $x chemie $x metabolismus $7 D003911
- 650 _2
- $a gliom $x farmakoterapie $x patologie $7 D005910
- 650 _2
- $a HeLa buňky $7 D006367
- 650 _2
- $a heparansulfát proteoglykany $x chemie $x metabolismus $7 D019812
- 650 _2
- $a endoteliální buňky pupečníkové žíly (lidské) $7 D061307
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a železo $x metabolismus $7 D007501
- 650 _2
- $a magnetické pole $7 D060526
- 650 _2
- $a magnetické nanočástice $x aplikace a dávkování $x chemie $7 D058185
- 650 _2
- $a transmisní elektronová mikroskopie $7 D046529
- 650 _2
- $a polylysin $x chemie $x metabolismus $x farmakokinetika $7 D011107
- 650 _2
- $a polysacharid-lyasy $x metabolismus $7 D011133
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Chang, Yi-Ting $u Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Guishan, Taoyuan, Taiwan, Republic of China. Department of Physiology and Pharmacology and Healthy Aging Research Center, College of Medicine, Chang Gung University, Guishan, Taoyuan, Taiwan, Republic of China.
- 700 1_
- $a Babič, Michal $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic.
- 700 1_
- $a Lu, Yi-Ching $u Department of Physiology and Pharmacology and Healthy Aging Research Center, College of Medicine, Chang Gung University, Guishan, Taoyuan, Taiwan, Republic of China.
- 700 1_
- $a Horák, Daniel $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic.
- 700 1_
- $a Ma, Yunn-Hwa $u Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Guishan, Taoyuan, Taiwan, Republic of China. Department of Physiology and Pharmacology and Healthy Aging Research Center, College of Medicine, Chang Gung University, Guishan, Taoyuan, Taiwan, Republic of China. Department of Neurology, Chang Gung Memorial Hospital, Guishan, Taoyuan, Taiwan, Republic of China.
- 773 0_
- $w MED00176143 $t International journal of nanomedicine $x 1178-2013 $g Roč. 13, č. - (2018), s. 1693-1706
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29599614 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180709 $b ABA008
- 991 __
- $a 20180712115934 $b ABA008
- 999 __
- $a ok $b bmc $g 1316412 $s 1021202
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 13 $c - $d 1693-1706 $e 20180320 $i 1178-2013 $m International journal of nanomedicine $n Int J Nanomedicine $x MED00176143
- LZP __
- $a Pubmed-20180709